Please check your internet connection and try again.
# Methycobalime (methylcobalamin)
## Overview
Methycobalime is a form of vitamin B12. Vitamin B12 is essential for red blood cell formation, neurological function, and DNA synthesis. Methylcobalamin is the active form of vitamin B12.
## Primary Indications
* Treatment of vitamin B12 deficiency.
* Adjunctive treatment of peripheral neuropathies.
## Adult Dosing
* **Vitamin B12 Deficiency:** Oral doses typically range from 1000 mcg to 2000 mcg daily. Parenteral administration may be required initially in severe deficiency or malabsorption states (e.g., 1000 mcg intramuscularly daily for one week, then weekly for one month, then monthly). Specific dosing and route will depend on the severity of deficiency and cause.
* **Peripheral Neuropathies:** Oral doses often range from 1500 mcg to 3000 mcg daily, sometimes divided.
## Pediatric Dosing
Dosing in children is not well established. Recommendations are often extrapolated from adult data or based on the severity of deficiency. Consult pediatric-specific guidelines or a pediatric specialist.
## Dose Adjustments
No dose adjustments are typically needed for renal or hepatic impairment for methylcobalamin.
## Contraindications
* Hypersensitivity to methylcobalamin or other cobalt-containing compounds.
## Adverse Effects
Generally well-tolerated. Potential adverse effects include:
* Allergic reactions (rash, itching)
* Diarrhea
* Nausea
* Headache
## Key Drug Interactions
* **Chloramphenicol:** May interfere with the hematopoietic response to vitamin B12.
* **Proton Pump Inhibitors (PPIs) and H2 Blockers:** May reduce absorption of oral vitamin B12.
* **Metformin:** May decrease vitamin B12 absorption.
## Monitoring
* Monitor for signs and symptoms of vitamin B12 deficiency (e.g., fatigue, weakness, neurological changes, glossitis).
* Monitor serum vitamin B12 levels if clinically indicated, especially when assessing treatment efficacy or compliance.
* Monitor for adverse effects.
## Clinical Pearls
* Oral absorption of vitamin B12 is highly dependent on intrinsic factor. Intramuscular or subcutaneous administration bypasses this absorption pathway and is preferred for patients with pernicious anemia or severe malabsorption.
* Long-term use of certain medications like metformin and acid-suppressing agents may necessitate vitamin B12 monitoring.
* Methylcobalamin is the active coenzyme form and may be preferred by some clinicians over cyanocobalamin, though clinical outcomes are often similar.
***
**Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant guidelines for complete and up-to-date details before making any clinical decisions.
